Search
Clinical Trial
A Phase I First-In-Human, Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors
… SIM0505 in Adult Participants with Advanced Solid Tumors I Zsiros, Emese This is an open-label, multicenter phase 1 …
Clinical Trial
A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY FOR LNCB74, A B7-H4 TARGETED ANTIBODY DRUG CONJUGATE, AS MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS
… MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS I Zsiros, Emese This is an open-label, phase 1, dose escalation …
Graduate Education
Clinical Oncology Year 2019 in Review Presentations
… George, MD, FACP Updates in Gynecologic Cancers / Emese Zsiros, MD, PhD, FACOG The Best of Sarcoma / Anne … George, MD, FACP Updates in Gynecologic Cancers / Emese Zsiros, MD, PhD, FACOG The Best of Sarcoma / Anne …
Graduate Education
Clinical Oncology Year 2019 in Review Presentations
… George, MD, FACP Updates in Gynecologic Cancers / Emese Zsiros, MD, PhD, FACOG The Best of Sarcoma / Anne … George, MD, FACP Updates in Gynecologic Cancers / Emese Zsiros, MD, PhD, FACOG The Best of Sarcoma / Anne …
Clinical Trial
A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Investigator s Choice (IC) in Patients with Platinum Resistant Ovarian Cancer
… in Patients with Platinum Resistant Ovarian Cancer III Zsiros, Emese This phase 3 study will be conducted in …
Clinical Trial
Randomized Phase 2 Clinical Trial of Pembrolizumab Combined with Bevacizumab with or without Agonist Anti-CD40 CDX-1140 in Patients with Recurrent Ovarian Cancer
… CDX-1140 in Patients with Recurrent Ovarian Cancer II Zsiros, Emese This phase II trial tests whether pembrolizumab …
Clinical Trial
Randomized Phase 2 Trial of APL-2 with Pembrolizumab vs. APL-2 with Pembrolizumab and Bevacizumab vs. Bevacizumab alone in Patients with Recurrent Ovarian Cancer and Persistent Malignant Effusion
… Ovarian Cancer and Persistent Malignant Effusion II Zsiros, Emese This phase II trial studies the effect of APL-2 …
Clinical Trial
A Phase 1a/1b Study of 27T51, an anti-MUC16 CAR T cell drug product administered alone or in combination for participants with recurrent or refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( 27T51-01)
… primary peritoneal, or fallopian tube cancer ( 27T51-01) I Zsiros, Emese This study is researching an experimental CAR T …
Clinical Trial
Life on the Go 3: A Randomized Controlled Trial of Automated, Personalized Physical Activity Intervention Using Wearable Devices to Improve Immune Function and Clinical Outcomes in Ovarian and Endometrial Cancer Patients
… Outcomes in Ovarian and Endometrial Cancer Patients N/A Zsiros, Emese This clinical trial compares the effect of an …
Education
Bi-Annual Gynecologic Cancer Seminar and the Retirement of Shashikant Lele, MD
… Leadership Roswell Park Comprehensive Cancer Center Emese Zsiros, MD, PhD Shashikant Lele, MD, Endowed Chair in … Roswell Park Comprehensive Cancer Center Emese Zsiros, MD, PhD Shashikant Lele, MD, Endowed Chair in …